Jean‐Luc Pagani - Concepedia

Author

Jean‐Luc Pagani

Also Known As

Florent Artru, J L Pagani, J. L. Pagani, J. Pagani, J.-L. Pagani, Jean-Luc Pagani, Jean‐Luc Pagani, Michael Osthoff, Pagani Jean-Luc, Pagani, Jean-Luc

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of Lausanne University Hospital of Lausanne University of Geneva University Hospital of Geneva University Hospital of Bern

About

Jean‐Luc Pagani is an author at University of Lausanne specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.4K
2	Health Sciences	1	1	814
3	Public Health	1	1	39
4	Epidemiology	1	1	39
5	Hospital Medicine	1	1	39

Jean‐Luc Pagani

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters Dominique Sanglard, Karl Kuchler, Françoise Ischer, Antimicrobial Agents and Chemotherapy Specific Multidrug TransportersAntifungal AgentAzole ResistanceHealth SciencesAntifungal Agents	1995	814
Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users Patrick Boerlin, Franziska Boerlin-Petzold, Christian Durussel, Journal of Clinical Microbiology Medical MicrobiologyOral CavitiesGerm Tube-positive CandidaClinical Infectious DiseaseVaginitis	1995	96
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial Bruno François, Hasan S. Jafri, Jean Chastre, The Lancet Infectious Diseases Pilot TrialClinical EffectivenessPatient SafetyClinical TrialsRespiratory Infection	2021	80
Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting Patrick Boerlin, Franziska Boerlin-Petzold, Jérôme Goudet, Journal of Clinical Microbiology Diagnostic MycologyOral IsolatesVitro SusceptibilityVaginitisVirology	1996	79
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia Yok‐Ai Que, Hedvika Lazar, Michel Wolff, European Journal of Clinical Microbiology & Infectious Diseases ImmunologyAdjunctive ImmunotherapyRespiratory InfectionInfectious Respiratory DiseaseInfection Control	2014	75
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients A Fournier, Philippe Eggimann, Jean‐Luc Pagani, Burns Drug SafetyTherapeutic Drug MonitoringEmpirical DosesIll Burn PatientsMedicine	2015	56
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study Jérôme Pugin, Thomas Daix, Jean‐Luc Pagani, Critical Care	2021	49
Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years Philippe Eggimann, Jean‐Luc Pagani, Elise Dupuis‐Lozeron, Intensive Care Medicine	2019	46
Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit A Fournier, Philippe Eggimann, Olivier Pantet, Antimicrobial Agents and Chemotherapy	2017	45
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients Stéphanie Bibert, Nicolas Guex, João Lourenço, Frontiers in Immunology	2021	41

Page 1